Malignancy in SARS-CoV2 infection

Study population: all the residents in the Veneto Region who were consecutively tested for SARS-CoV-2 infection between February 22nd and April 1st, 2020. Study variables: · demographics (age, sex) · history of malignant disease (prevalent diagnosis of malignant cancer, cancer site, interval between diagnosis of cancer and testing for SARS-CoV-2 infection) · clinical outcomes of SARS-CoV-2 infection (admission to hospital; admission to Intensive Care Unit; death)研究人群：2020年2月22日至4月1日期间连续接受严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染检测的威尼托大区全体居民。 研究变量： · 人口统计学特征（年龄、性别） · 恶性疾病病史（恶性肿瘤现患诊断、肿瘤部位、癌症确诊至SARS-CoV-2感染检测的间隔时长） · 严重急性呼吸综合征冠状病毒2感染的临床结局（住院治疗、重症监护病房（Intensive Care Unit）收治、死亡）